Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | Y472C |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF Y472C lies within the protein kinase domain of the Braf protein (UniProt.org). Y472C results in impaired Braf kinase activity, but paradoxically increases Mek and Erk signaling through C-raf transactivation (PMID: 22649091), however in two different cell lines, Y472C induces similar cell proliferation and cell viability as compared to wild-type Braf (PMID: 29533785), and therefore, its effect on Braf protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF Y472C |
Transcript | NM_004333.6 |
gDNA | chr7:g.140781593T>C |
cDNA | c.1415A>G |
Protein | p.Y472C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001354609.2 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140781593T>C | c.1415A>G | p.Y472C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF Y472C | lung non-small cell carcinoma | sensitive | Dasatinib | Preclinical - Cell culture | Actionable | In a preclinical study, Sprycel (dasatinib) induced apoptosis in non-small cell lung carcinoma cells harboring BRAF Y472C in culture (PMID: 22649091). | 22649091 |